Fingolimod is an immunomodulating drug, which is used to prevent incidences of symptoms and can slow the worsening of disability in patients with relapsing problems such as multiple sclerosis (MS). MS is a disease where the nerves fail to function properly and the patient may experience numbness, loss of muscle coordination,weakness, and problems with speech, vision, and bladder control. Fingolimod is a sphingosine 1-phosphate receptor modulator. It works by decreasing the action of the immune cells that can cause damage to the nerves. Fingolimod may cause a slowed heartbeat, especially during the first six weeks after taking the medicine. Because of this, the first dose of fingolimod will be given in a hospital where medical professionals can monitor your reaction.